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Abstract 
Background: In type 1 diabetes mellitus (T1DM) management, enhancing health‑related quality of life (HRQoL) 
is as important as good metabolic control and prevention of secondary complications. This study aims to evaluate 
possible regional differences in HRQoL, demographic features and clinical characteristics of patients with T1DM in 
Brazil, a country of continental proportions, as well as investigate which variables could influence the HRQoL of these 
individuals and contribute to these regional disparities.
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Background
Type 1 diabetes mellitus (T1DM) affects the psycho-
logical and emotional well-being of patients and their 
families [1] and, in diabetes management, enhancing 
health-related quality of life (HRQoL) is as important 
as good metabolic control and prevention of second-
ary complications [2]. However, studies examining the 
HRQoL of people with T1DM are still limited [3]. This is 
the first multicenter population-based study on this topic 
conducted in the Southern hemisphere.
When studying this aspect, it is essential to first estab-
lish the conceptual difference between the terms quality 
of life (QoL), HRQoL, quality of health and health status. 
QoL is a multifaceted and highly subjective concept, and 
has been defined as “how good or bad a person feels their 
life to be” [4, 5]. The most suitable instruments to assess 
QoL are World Health Organization Quality of Life 
(WHOQOL), diabetes quality of life (DQOL) and audit 
of diabetes-dependent quality of life (ADDQoL) [4]. In 
contrast, HRQoL, quality of health and health status are 
more specific terms, and refer to how people feel about 
their physical and mental health [6]. HRQoL is more 
accurately measured by Short-Form 36 (SF-36) and Euro-
QoL 5-dimension (EQ-5D) [4].
With continental proportions, Brazil is the fifth larg-
est country in the world, and covers a total area of over 
8 million Km2. According to the latest population census, 
conducted in 2010 by the Brazilian Institute of Geogra-
phy and Statistics (IBGE), Brazil has an estimated popu-
lation of 190 million people, resulting in a demographic 
density of 22.5 inhabitants/km2 [7]. The Southeast region 
presents the highest population density, with 42 % of the 
Brazilian residents, followed by Northeast (27.7 %), South 
(14.3 %), North (8.5 %) and Midwest (7.5 %) [8].
Brazil is marked by its regional disparities, mainly cen-
tered on North and Northeast’s relative backwardness 
and predominantly unfavorable indicators [9]. According 
to IBGE’s survey, in 2013, Northeast and North presented 
the lowest urbanization rates (73.3 and 74.6  %, respec-
tively) and the highest infant mortality rates (19.4 and 
19.2 deaths per 1000 live births, respectively). Moreover, 
when compared to the other geographical regions, the 
North-Northeast region showed worse basic sanitation 
and health care provision indicators, higher fecundity 
and illiteracy rates, and lower asset ownership and per-
centage of people in formal work [7, 8].
In order to explore the possible impact of the notice-
able regional heterogeneity of Brazil on health care and 
HRQoL in a selected group of people, the Brazilian Type 
1 Diabetes Study Group (BrazDiab1SG) performed a 
survey that analyzed the demographic, clinical, labora-
torial and economic data of 3591 patients with T1DM 
who received medical care at public clinics among all five 
geographical regions of Brazil. The purpose of the pre-
sent study was to evaluate possible regional differences 
in HRQoL of patients with T1DM in Brazil, as well as 
investigate which variables could influence the HRQoL 




The BrazDiab1SG performed a retrospective, cross-
sectional and multicenter study on people with T1DM 
between December 2008 and December 2010, in 28 pub-
lic clinics of the secondary and tertiary care level, located 
in 20 cities (population greater than 100,000), in the five 
Brazilian geographical regions (North, Northeast, South-
east, South and Midwest). For statistical purposes, North 
and Northeast were grouped.
Patients
All patients received health care from the National Bra-
zilian Health Care System (NBHCS), and were treated 
Methods: This was a retrospective, cross‑sectional, multicenter study performed by the Brazilian Type 1 Diabetes Study 
Group (BrazDiab1SG), by analyzing EuroQol scores from 3005 participants with T1DM, in 28 public clinics, among all 
geographical regions of Brazil. Data on demography, economic status, chronic complications, glycemic control and 
lipid profile were also collected.
Results: We have found that the North‑Northeast region presents a higher index in the assessment of the overall 
health status (EQ‑VAS) compared to the Southeast (74.6 ± 30 and 70.4 ± 19, respectively; p < 0.05). In addition, North‑
Northeast presented a lower frequency of self‑reported anxiety‑depression compared to all regions of the country 
(North‑Northeast: 1.53 ± 0.6; Southeast: 1.65 ± 0.7; South: 1.72 ± 0.7; Midwest: 1.67 ± 0.7; p < 0.05). These findings 
could not be entirely explained by the HbA1c levels or the other variables examined.
Conclusions: Our study points to the existence of additional factors not yet evaluated that could be determinant in 
the HRQoL of people with T1DM and contribute to these regional disparities.
Keywords: Type 1 diabetes mellitus, Health‑related quality of life, EuroQol
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by an endocrinologist in secondary or tertiary care set-
tings. Were included on this study patients diagnosed 
with T1DM by a physician (based on a typical clinical 
presentation as well as the need of using insulin con-
tinuously since the diagnosis), with follow-up time in 
each center greater than or equal to 6 months, and older 
than 10  years old. Exclusion criteria were pregnancy or 
lactation (excluded by self-report), and history of acute 
infectious processes or diabetic ketoacidosis in the three 
months prior to assessment.
Clinical and laboratorial data
Data of interest for the analysis of HRQoL were obtained 
from questionnaires self-completed by the patients, 
in addition to records obtained from medical charts. 
Trained physicians interviewed and examined all patients 
according to a standardized protocol, assessing cur-
rent age, age at diagnosis of T1DM, duration of diabe-
tes (years), monthly family income in minimum wages, 
economic class, physical activity, height (m), weight (kg), 
blood pressure (mmHg), insulin therapy regimen, dia-
betes-related comorbidities and smoking status (defined 
as smoking more than one cigarette per day at the time 
of the interview). Body mass index (BMI) (kg/m2) was 
determined by dividing the weight (kg) by height (m) 
squared. Practice of physical activity was addressed by a 
questionnaire that considered (1) only on weekends, (2) 
two to three times per week, (3) three to five times per 
week, (4) more than five times per week, and (5) no phys-
ical activity. For statistical analysis, we considered only 
whether patients practiced physical activity or not.
The economic status was defined according to the 
Brazilian Economic Classification Criteria [10], which 
considers asset ownership, access to public services and 
education level (categorized as illiterate/incomplete pri-
mary education, complete primary education/incomplete 
secondary education, complete secondary education/
incomplete high school, complete high school/some col-
lege, or complete college education). For this analysis, 
the economic classes considered were high (A), medium 
(B1–B2), low (C1–C2) and very low (D–E).
The levels of glycated hemoglobin (HbA1c), fasting 
plasma glucose (FPG), total cholesterol, low-density 
lipoprotein (LDL) cholesterol, high-density lipoprotein 
(HDL) cholesterol, and triglycerides measured dur-
ing the last clinical visit were obtained from the par-
ticipants’ medical records. HbA1c values were obtained 
using high-performance liquid chromatography (HPLC) 
in 54.6 % and turbidimetry and in 40 % of cases; in the 
remaining patients we used other methods. Levels of 
fasting and postprandial glycemia, total cholesterol, 
HDL cholesterol and triglycerides were measured by 
enzymatic techniques. LDL cholesterol level was cal-
culated using the Friedewald’s equation. The Ameri-
can Diabetes Association’s (ADA) goals for adequate 
metabolic and clinical control were adopted by the 
BrazDiab1SG.
Within 1  year of the study assessment, people with a 
diabetes duration greater than or equal to 5  years from 
diagnosis were screened for the following chronic diabe-
tes-related complications: microvascular diseases (classi-
fied as retinopathy, clinical nephropathy and peripheral 
neuropathy) and macrovascular diseases (classified as 
clinical coronary artery disease, stroke, peripheral vascu-
lar disease and foot pathologies).
Each center’s local ethics committee approved the 
study. Written informed consent was obtained from all of 
the patients or their parents.
Health‑related quality of life assessment
HRQoL was assessed by the EuroQol [11], which 
includes two tools: the EQ-5D and the EQ-VAS. The 
first one analyzes descriptively five dimensions of 
problems (mobility, self-care, usual activities, pain and 
discomfort, and anxiety and depression) on a scale of 
three scores, graded from 1 to 3 (1 “I have no prob-
lems”, 2 “I have some problems”, 3 “I have extreme 
problems”). The EQ-VAS (overall health status) con-
sists of an analog scale from 0 (very bad state of 
health) to 100 (optimal health status), for the patient 
to check or tell a value that reflects their perception of 
state of health. The EuroQol is not reliable in individu-
als younger than 10  years old. Therefore, these par-
ticipants were excluded from the initial sample. The 
Portuguese version of the EQ-5D questionnaire has 
been proven accessible, reliable and valid in measur-
ing health status in a study conducted in Portugal [12]. 
Additionally, in Brazil, Pinto et  al. [13] demonstrated 
the reproducibility and validity of EuroQol on stroke 
patients.
Data collected using EQ-5D can be presented in vari-
ous ways: presenting results from the descriptive system 
as a health profile, presenting results of the EQ-VAS as 
a measure of overall self-rated health status, and pre-
senting results from the EQ-5D index value. In order to 
obtain the EQ-5D index value, it is required a general 
population-based value set (as opposed to a patient-
based set). The rationale behind this is that the values 
are supposed to reflect the preferences of local taxpay-
ers and potential receivers of healthcare. However, in 
Brazil, there is not a population-based index available 
yet. Information in the single index format is useful, for 
example, in cost utility analysis, which is not the purpose 
of the present study.
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Statistical analysis
The study sample represented the distribution of T1DM 
cases across four geographical regions in Brazil, esti-
mated using the overall population distribution reported 
in the IBGE’s population census of 2000 [14]. These data 
were combined with the national estimates of diabetes 
prevalence, which were derived from a 1988 survey, to 
determine the minimum number of patients to be stud-
ied in each region [15]. 3457 patients would be neces-
sary to identify a proportion of patients with adequate 
glycemic control of 10  %, with a 95  % confidence and a 
margin of error of 1 %. This number was rounded to 3500 
patients and distributed among the four geographical 
regions [North-Northeast: 1259 (35.7 %); Southeast: 1492 
(42.6 %); South: 518 (14.8 %); and Midwest: 240 (6.9 %) 
individuals]. A total of 3591 patients were included in 
this study. Participants younger than 10  years old were 
excluded from the initial sample of 3591 individuals, so 
that the final sample comprised 3005 patients [North-
Northeast: 925 (30.8 %); Southeast: 1180 (39.3 %); South: 
718 (23.9 %); and Midwest: 182 (6.1 %)].
Categorical variables were presented as frequency (per-
centage). All normally distributed values were given as 
mean ± standard deviation (SD) and all other values were 
given as median (range). We used Chi squared and Fisher 
tests to compare categorical data, and T-student and 
Man-Whitney tests for comparisons between two groups 
with numeric variables. To test the differences among 
more than two groups, analysis of variance (ANOVA) 
was performed for all normally distributed variables, and 
Kruskal–Wallis test was used for the non-normally dis-
tributed variables. For multiple comparisons, the Tukey 
test (post hoc) was used. For correlation analysis, Pearson 
or Spearman tests were used.
A two-sided p  <  0.05 was considered statistically sig-
nificant. All data was stored and processed by EPIINFO 
2000 and analyzed using the Statistical Package for the 
Social Sciences version 21.0 (IBM, Chicago, IL, USA) and 
Sigma Stat version 3.5 (Jandel Scientific Corporation, 
Chicago, IL, USA).
Results
The general demographic, clinical and laboratorial data 
of the assessed population are shown in Table 1.
The average score assigned to general health (EQ-VAS) 
by people with Type 1 DM in Brazil was of 72.5  ±  22. 
Analyzing the EuroQol results in each geographical 
region separately, we have found that the North-North-
east region presents a higher index in the assessment 
of the overall health status compared to the Southeast. 




Age, years ± SD 23.9 ± 10.8
Women, n (%) 1700 (56)
Age at diagnosis of T1DM in years, n (%)
 0–4.9 330 (11)
 5–9.9 721 (24)
 10–14.9 932 (31)
 15–19.9 492 (16.4)
 20–29.9 414 (13.5)
 ≥30 126 (4.1)
Mean age at diagnosis of T1DM, years ± SD 13 ± 7.9
Duration of T1DM, years 10.9 (7 months–50 years)
Ethnicity, n (%)
 Caucasian 1720 (57.2)
 Non‑Caucasian 1285 (42.8)




 Very low 66.1
Geographical region, n (%)
 Southeast 1180 (39.3)
 North‑Northeast 925 (30.8)
 South 718 (23.9)
 Midwest 182 (6.0)
Monthly family income, number of minimum 
wages ± SD
2.3 ± 1.4
Practice of physical activity, n (%) 1723 (57 %)
Smokers, n (%) 150 (5 %)
Microvascular complications, n (%) 673 (29.6)
Macrovascular complications, n (%) 124 (5.5)
Systolic blood pressure, mmHg ± SD 113 ± 16
Diastolic blood pressure, mmHg ± SD 73 ± 11
BMI, kg/m2 22.6 ± 3.9
HbA1c, % (mmol/mol) 9.4 ± 2.4 (79 ± 3)
Fasting plasma glucose, mmol/l 10.2 ± 5.8
Total cholesterol, mmol/l 4.4 ± 1.1
Triglycerides, mmol/l 1.1 ± 0.8
LDL cholesterol, mmol/l 2.6 ± 2.1
HDL cholesterol, mmol/l 1.4 ± 0.4
T1DM treatment, %
 Intermediate‑acting insulin 16.3
 Long‑acting insulin 1.3
 Insulin pump 1.5
 Intermediate‑ or long‑ and short‑acting insulin 80.8
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Additionally, the EQ-5D showed a markedly lower fre-
quency of self-reported anxiety-depression in the North-
Northeast compared to the other regions of the country 
(Table 2).
The economic status of patients in each geographical 
region of Brazil is presented on Table 3. We detected that 
63.3 % of patients in the Southeast, 56.5 % in the South, 
55.5 % in the Midwest and 85.6 % in the North-Northeast 
region were classified as belonging to low or very low 
economic class.
Furthermore, we evaluated the clinical and laborato-
rial variables that could influence the HRQoL of type 1 
diabetic patients in the different geographical regions of 
Brazil (Table 4).
On Table  5, we present the correlation between EQ-
VAS and the variables that could interfere with HRQoL.
Table 2 Euroqol results in  T1DM patients of  the North-
Northeast, Southeast, South and Midwest regions of Brazil
NS not significant
┼ p < 0.05 between North-Northeast versus Southeast
╞ p < 0.05 between South versus Southeast
┬ p < 0.05 between North-Northeast versus Midwest
╪ p < 0.05 between North-Northeast versus Southeast, South and Midwest
North‑ 
Northeast
Southeast South Midwest p
EQ‑VAS score 74.6 ± 30┼ 70.4 ± 19 73.3 ± 17╞ 71.4 ± 19 <0.05
Mobility 1.06 ± 0.2 1.08 ± 0.3 1.08 ± 0.2 1.1 ± 0.3 NS
Self‑care 1.03 ± 0.2 1.03 ± 0.2 1.02 ± 0.2 1.02 ± 0.2 NS
Usual activities1.08 ± 0.3 1.1 ± 0.3 1.1 ± 0.3 1.15 ± 0.4 NS
Pain and 
discomfort
1.33 ± 0.5┬ 1.37 ± 0.6 1.37 ± 0.5 1.48 ± 0.5 <0.05
Anxiety and 
depression
1.53 ± 0.6╪ 1.65 ± 0.7 1.72 ± 0.7 1.67 ± 0.7 <0.05
Table 3 Economic status assessment of T1DM patients in each geographical region of Brazil
╪ p < 0.05 between North-Northeast versus Southeast, South and Midwest
╦ p < 0.05 between North-Northeast versus South and Southeast
╞ p < 0.05 between South versus Southeast
Economic class North‑Northeast (%) Southeast (%) South (%) Midwest (%) p
High 3.8╪ 8 10.9 12.6 <0.05
Medium 10.6╪ 28.7 32.6 31.9 <0.05
Low 29.9╦ 36 37.7 30.2 <0.05
Very low 55.7╪ 27.3 18. 8╞ 25.3 <0.05
Table 4 Clinical and laboratorial variables and their influence on the QoL of T1DM patients in each geographical region 
of Brazil
NS not significant
╪ p < 0.05 between North-Northeast versus Southeast, South and Midwest
╦ p < 0.05 between North-Northeast versus South and Southeast
┼ p < 0.05 between North-Northeast versus Southeast
╞ p < 0.05 between South versus Southeast
╝ p < 0.05 between South versus North-Northeast, Southeast and Midwest
Variables North‑Northeast Southeast South Midwest P
Mean age (years ± SD) 22.5 ± 9╪ 24.6 ± 11 24.4 ± 11 25.6 ± 10 <0.05
Monthly family income (number of minimum wages ± SD) 2.12 ± 1╪ 2.49 ± 1.6 2.42 ± 1.3 2.47 ± 1.3 <0.05
Practice of physical activity (n) 499 (54 %) 635 (53 %) 492 (68 %)╝ 97 (53 %) NS
Duration of Type 1 DM (years ± SD) 8.6 ± 6.6╦ 12.2 ± 8.9 11.6 ± 8.4 10.3 ± 7.8 <0.05
HbA1c (% ± SD) 9.6 ± 2.6┼ 9.2 ± 2.4 9.5 ± 2.1 9.2 ± 2.7 <0.05
Fasting plasma glucose (mg/dl) 185 ± 112 187 ± 109 174 ± 93 171 ± 99 NS
Microvascular complications (%) 22.9╦ 32.4 32 32.1 <0.05
Macrovascular complications (%) 4┼ 7.2╞ 4.3 5.2 <0.05
Micro and macrovascular complications (%) 24.8╦ 35.5 33.8 32.8 <0.05
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Discussion
This is the first population-based study to evaluate the 
HRQoL of people with T1DM in the Southern hemi-
sphere, in a country of continental proportions and 
marked by major regional disparities such as Brazil.
Due to the magnitude of the differences observed 
among the geographical regions, the pattern that emerges 
can be defined as markedly asymmetrical. South has, in 
general, more favorable health indicators than the other 
regions, as well as a higher degree of homogeneity. The 
other regions show polarized structures, with North and 
Northeast presenting predominantly unfavorable indica-
tors, and Southeast and Midwest featuring mostly favora-
ble indicators. A nationwide study on health disparities in 
Brazil, promoted by the Brazilian Ministry of Health and 
the Pan-American Health Organization, suggests that 
three variables seem to explain, in statistical terms, these 
differences found between the geographical regions, 
namely: urbanization, poverty and aspects related to the 
organization of health services. Urbanization suggests 
the exposure to a “modern” pattern of risk factors. Pov-
erty refers to the difficulties involved in obtaining goods 
and services directly or indirectly associated to health. 
Finally, health services can increase or promote health 
inequalities. In this respect, two variables should be high-
lighted: access and quality of health services [9].
However, despite these data, the present study has 
found that the North-Northeast region presents a higher 
index in the assessment of the overall health status com-
pared to the Southeast, along with a significantly lower 
frequency of self-reported anxiety-depression compared 
to all regions of the country. These findings are contro-
versial and cannot be entirely explained by the variables 
we examined in our study.
The effect of glycemic control on HRQoL of people 
with T1DM remains unclear, with conflicting studies 
pointing to opposite directions. A study including teen-
agers with T1DM suggested that even those who are suc-
cessfully achieving HbA1c goals of therapy may perceive 
diabetes as having a negative impact on their lives, be 
depressed, and find diabetes difficult to manage [16]. In 
contrast, in a series of over 2000 adolescents with T1DM, 
Hoey et al. [17] have found that better HbA1c levels were 
associated with lower impact, fewer worries, greater sat-
isfaction, and better health perception. In the present 
study, we have found a correlation between HbA1c levels 
and EQ-VAS. However, our results showed higher lev-
els of HbA1c as well as higher EQ-VAS scores in North-
Northeast in comparison to Southeast. Therefore, the 
better health perception observed in North-Northeast 
could not be explained by the difference of HbA1c lev-
els. Additionally, the remaining variables that could affect 
HRQoL individually showed poor correlation with health 
status.
Regarding the economic status, a cross sectional 
descriptive study, using a semi structured questionnaire, 
with 103 diabetic patients, suggested that social class has 
a significant impact on HRQoL and therapy compliance. 
The mean scores for general health on upper, middle and 
lower class were 3.49 ± 0.837, 2.96 ± 0.706, 2.63 ± 0.744 
respectively [18]. However, in our study the regions with 
the highest percentage of people classified as belong-
ing to low or very low economic class, and the lowest 
monthly family income presented the best HRQoL indi-
cators, which is also paradoxical.
A possible explanation for the better general health 
status and the lower frequency of self-reported anxiety-
depression in North-Northeast is the lower incidence of 
chronic complications and the shorter duration of dia-
betes found in this region. These findings are consist-
ent with other studies. Redekop et  al. [19] showed that 
patients with microvascular complications had lower 
indexes of HRQoL compared to those without chronic 
complications, even after adjusting for other factors. In 
addition, other studies suggest that the presence of clini-
cal complications of diabetes have potentially significant 
impact on HRQoL, since the greater the number of com-
plications, the worse the HRQoL [20]. Furthermore, the 
BrazDiab1SG, evaluating the HRQoL in Brazil without 
distinguishing the geographical regions (data not pub-
lished yet), found weak correlations between the EQ-VAS 
scores and the micro and macrovascular complications 
and diabetes duration. Additionally, a linear regression 
analysis was performed and showed low impact of diabe-
tes complications and diabetes duration on the EQ-VAS 
score. These data reinforce the hypothesis that there are 






Duration of diabetes −0.1 <0.05
Practice of physical activity 0.15 <0.05
Economic status −0.05 <0.05
Monthly family income 0.03 NS
Fasting plasma glucose −0.1 <0.05
HbA1c −0.2 <0.05
Microvascular complications −0.1 <0.05
Macrovascular complications −0.1 <0.05
Micro and macrovascular complications −0.1 <0.05
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other factors, not yet evaluated, that could influence the 
HRQoL.
Regarding the impact of age on HRQoL, a study evalu-
ated patients with type 2 diabetes using the EQ-5D and 
found that anxiety-depression was more frequently 
reported by younger patients. A possible explanation for 
this result was that the projection of future disease pro-
gression is more stressful for younger patients. Therefore, 
the fact that the patients in the North-Northeast region 
have shown a lower prevalence of anxiety-depression 
compared to other regions of the country could not be 
justified by those being younger.
In summary, our results cannot be entirely explained 
by the variables we examined, such as diabetes duration, 
chronic complications, HbA1c, age and economic sta-
tus, suggesting the existence of additional factors not yet 
evaluated that could be determinant of HRQoL in those 
individuals.
It has been reported that diabetes mellitus is associ-
ated with lower levels of vitamin D [21], which might 
increase the prevalence of numerous comorbidities, such 
as depression [22]. In our study, the higher EQ-VAS score 
and lower frequency of self-reported anxiety-depression 
in the North-Northeast region of Brazil may perhaps be 
influenced by vitamin D deficiency. Decreased vitamin D 
levels tend to be more common in regions of lower sun-
light exposure, such as the South and Southeast of Brazil. 
In a study of 102 non-institutionalized and low-income 
elderly, in Porto Alegre (Brazilian South region), the 
prevalence of vitamin D deficiency reached 85.7 % [23]. 
On the other hand, a study in children in Recife (Brazil-
ian Northeast region) virtually detected no cases of vita-
min D deficiency [24].
Other factor possibly related to a poorer HRQoL could 
be the stressful lifestyle of largely populated cities. The 
lower frequency of anxiety-depression found in Brazil-
ian North-Northeast, a region with smaller population 
density, reinforces that hypothesis. The role of lifestyle 
modification in improving patients’ quality of life, how-
ever, is poorly understood. A few studies have shown that 
lifestyle factors, such as not smoking, getting adequate 
leisure time physical activity, having a healthy diet and 
proper sleep and work time, are associated with better 
HRQoL among people with and without diabetes [25, 
26].
The main strength of this study is the recruitment of a 
large and representative sample of patients with T1DM 
from each geographical region, in a country of continen-
tal proportions such as Brazil, allowing the construction 
of a national database for a follow-up of these individuals 
in the long term. Further studies may elucidate the addi-
tional variables involved on the HRQoL of these patients, 
pointing to the need of possible structural, economic 
and health care-related improvements in each region of 
the country. We are currently conducting a more specific 
study on this topic in the North region, which may add, 
in the future, to the results we have already found. The 
limitations of this study were: (1) the lack of standardi-
zation for the assessment of HbA1c, which could have 
influenced the results; (2) the self-report nature of doc-
tor-diagnosed diabetes, as there could be misclassifica-
tion of diabetes, once C-peptide and autoantibodies were 
not measured.
Conclusions
In conclusion, this is the first population-based study 
to assess the HRQoL of people with Type 1 DM in the 
Southern hemisphere and in a country like Brazil, of con-
tinental proportions and marked by major regional dis-
parities. We have found that the North-Northeast region 
presents a higher index in the assessment of the overall 
health status compared to the Southeast, along with a 
significantly lower frequency of self-reported anxiety-
depression compared to all regions of the country, which 
could not be entirely explained by the HbA1c levels or 
the other variables examined. Thus, our study points to 
the existence of additional factors not yet evaluated that 
could be determinant in the quality of life of people with 
Type 1 DM and contribute to these regional disparities.
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